Results from ongoing study suggest the major role of Celartics' Cov-DCVax in preventing viral infection of COVID-19 and in controlling progression of the virus-associated diseasesBeijing, May 22, 2020, Celartics Biopharma announced today the filing of a patent application covering a novel dendritic cell (DC)-based vaccine, Cov-DCVax, to fight viral infection of COVID-19. The results, led by Celart
10 Item Per Halaman (Laman 1 / 1) Jumlah 5 Item
02-19
02-09
02-07
02-05
01-14
01-13
12-28
12-25
12-24
12-21